Listen to this podcast on your favourite podcast player: https://lnkd.in/eGemZRTi

New methods such as diagnostics need to be assessed and the included in the reimbursement catalogue in the outpatient setting in Germany. However, key question remains which requirements are needed for such an evaluation and who is responsible for it. In some instances the responsible body is a sub-committee of the German federal Committee (G-BA) the so-called evaluation committee. But how does that body come to a conclusion and what do they really assess. How does price setting work in such an environment.

The reimbursement veteran Dr. Stefan Walzer discussed all of these questions and many more secrets with the Head of the arbitration board of the before-mentioned evaluation committee, Prof. Jürgen Wasem.

✏️ Take the chance to stay connected and subscribe with your favourite podcast platform: https://lnkd.in/dyTZ3yQb

MAP is the first and only bi-weekly #marketaccesspodcast provided by MArS. For more information about MArS Market Access & Pricing Strategy GmbH visit: https://lnkd.in/db8aQWf

#podcasthost #podcastshow #podcastepisode #marketaccess #marketaccesspodcast #reimbursement #pricingstrategy #negotiations

#pricing #medtech #diagnostics #arbitrationboard #funding #medicaldevices #germany